Immediate and Late Outcomes of Bronchial and Systemic Artery Embolization for Palliative Treatment of Patients With Nonsmall-Cell Lung Cancer Having Hemoptysis( E, n- h R, O- z. |9 M4 Z) B6 e
Background: Hemoptysis in patients with advanced lung cancer can be a life threatening. 8 ~4 A3 y4 Y7 _9 H9 \( JObjectives: To evaluate immediate outcomes and late outcomes of bronchial artery embolization (BAE) for palliative treatment in patients with advanced nonsmall-cell lung cancer (NSCLC) having hemoptysis. / K. a2 l/ [) S' G. M7 _1 r7 VMethods: The BAE was performed in 28 patients with NSCLC. Hemoptysis was defined as follows: massive bleeding greater than 300 mL within 24 hours (n = 8), moderate bleeding of 100 to 300 mL within 24 hours (n =12), and slight bleeding less than100 mL within 24 hours (n = 8). ( a( M# e$ H& w! YResults: Success rate was 96%. Immediate clinical success within 24 hours after BAE was achieved in 22 of the 27 patients who underwent embolization. ) R1 J d5 F4 ]6 i/ S! I; JConclusions: The BAE with gelatin sponge particles can provide good management of hemoptysis as a palliative treatment in patients with advanced NSCLC.